Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation

NCT01999764 is registered in ClinicalTrials.gov with QLT Inc. as lead sponsor.

NCT NCT01999764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01999764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation
Lead sponsor
QLT Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2013
Completion date
July 31, 2014
Enrollment
43 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

impaired dark adaptation